Hemophilia Treatment
血友病治疗
Duration
Lifelong management with annual comprehensive reviews
Recovery
Ongoing prophylaxis, acute bleeds resolve in days
Savings
~88% vs US
Average savings compared to US prices
Comprehensive hemophilia management including prophylactic factor replacement, extended half-life products, non-factor therapies (emicizumab), and gene therapy evaluation. China's hemophilia treatment centers provide multidisciplinary care addressing bleeding prevention, joint protection, and emerging curative approaches. Significant cost advantages for factor concentrates and bispecific antibody therapies.
Comprehensive Assessment
Factor level testing, inhibitor screening, joint assessment with MRI, and genotyping for severity classification
Duration: 2-3 daysProphylaxis Initiation
Selection and initiation of optimal prophylactic regimen (standard or extended half-life factor, or emicizumab)
Duration: 2-4 weeksJoint Health Program
Physiotherapy, joint preservation strategies, and assessment for synovectomy or joint replacement if needed
Duration: OngoingGene Therapy Evaluation
Assessment for emerging gene therapy trials and novel treatments with potential for functional cure
Duration: Consultation- Access to modern prophylaxis at significantly reduced cost
- Emicizumab and extended half-life products available
- Comprehensive multidisciplinary hemophilia center care
- Potential access to gene therapy clinical trials
- Inhibitor development against replacement factors
- Breakthrough bleeding despite prophylaxis
- Joint damage if treatment delayed or inadequate
- Gene therapy still experimental with uncertain long-term outcomes
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.